Everolimus plus trastuzumab and vinorelbine for trastuzumab-resistant, taxane-pretreated, HER2+ advanced breast cancer: Overall survival results from BOLERO-3
Isaacs, C O'Regan, R Xu, B Masuda, N Arena, F Yap, Y-S Papai, Z Lang, I Armstrong, Anne C Lerzo, G
Isaacs, C
O'Regan, R
Xu, B
Masuda, N
Arena, F
Yap, Y-S
Papai, Z
Lang, I
Armstrong, Anne C
Lerzo, G
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2016
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Everolimus plus trastuzumab and vinorelbine for trastuzumab-resistant, taxane-pretreated, HER2+ advanced breast cancer: Overall survival results from BOLERO-3. 2016, 76 (4 Supplement):P4-13-12 Cancer Research